- Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants - Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG rise and a 19.9-fold ACE2 inhibition increase after booster dose - Immune responses in adolescents were 2- to 4-fold higher than adults against broad array of variants of interest and variants of concer

SEOUL, South Korea, Dec. 22, 2021 /PRNewswire/ -- Bitnine Global Inc, a graph database R&D company, was listed on the stock market (KOSDAQ) in November. KOSDAQ is Korea's electronic stock market, led by technology-based venture companies. Bitnine's market debut is the first specialized graph DB company in the world and the first database company in Korea. It is evaluated that this is attributed to Bitnine's technical competitiveness, future growth, and economic feasibility bas

YICHANG, China, Dec. 22, 2021 /PRNewswire/ -- Angel Enzyme Preparation (Yichang) Co., Ltd., ("Angel Enzyme Preparation"), a wholly-owned subsidiary of Angel Yeast Co., Ltd., is well underway with construction on its new green manufacturing project in Angel Biotechnology Industrial Park, Xiaoting District, Yichang City, which commenced in September 2021. Once complete, the project will have an annual enzyme production output of 5,000 tons and will significantly enhance the compan

New products via FP Markets Metatrader 4 (MT4) & Metatrader 5 (MT5) Platform include Bonds, Commodities, Cryptocurrency CFDs and Equities. SYDNEY, Dec. 22, 2021 /PRNewswire/ -- FP Markets has expanded its offering by adding new products on the FP Markets MT4 & MT5 Platforms. Recently awarded as the 'Best FX Broker Australia' 2021 for a second consecutive year, FP Markets continues to set the benchmark in CFDs and Forex and is pleased to announce it has added the following produc

"Awards Showcase Innovation Coming out of R&D Teams Across the Industry" SHANGHAI, Dec. 22, 2021 /PRNewswire/ -- TVU Networks, the live broadcast innovation and technology leader, was selected for two "Best of 2021" awards yesterday for its TVU Channel solution from two highly regarded industry publications - TV Technology and TVBEurope. Both award programs recognize outstanding broadcast products and solutions from the last 1

- Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries - Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202.5 Million in Future Milestones, Plus Tiered, Double-digit Royalties on Net Sales NEWTON, Mass. and FLORENCE, Italy, Dec. 22, 2021 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a c

- WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older - SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emergency Use Listing for Novavax' vaccine GAITHERSBURG, Md., Dec. 22, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-genera